{
  "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
  "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
  "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 54,
  "pageCount": 56,
  "prevPage": 53,
  "nextPage": 55,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a comparative layout contrasting a list of competitor assets with the specific benefits of the company's own asset (ERAS-601).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/54",
  "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
  "deckJsonHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9.json",
  "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-54",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.36,
        "x": 0.13,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "CLINICAL",
      "attrs": null,
      "subkind": "other",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3064062-f31e-4c59-87d9-4a0de42d05df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.53,
        "y": 0.68
      },
      "kind": "list",
      "text": "Although SHP2i expected to have its greatest impact in combination, ERAS-601 achieved monotherapy cPR (BRAF Class III endometrial)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a45b244-760d-4aae-836d-855a1dd0e5bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.53,
        "y": 0.45
      },
      "kind": "list",
      "text": "Clinical data to-date suggests ERAS-601 is generally safe and tolerable with reversible AEs; Favorable for combinations",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "595cf9b1-ab9b-4ff3-9f59-16c5752eeeb5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.53,
        "y": 0.22
      },
      "kind": "list",
      "text": "Strong in vivo potency relative to other SHP2's in development; Good exposure above IC50 for sustained target coverage",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac7c44cf-5027-4722-b79a-b40c62190f1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.53,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "LVEF: left ventricular ejection fraction; cetux: cetuximab; osi: osimertinib; PR: partial response; cPR: confirmed partial response",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d32c41f-5e6d-4cfd-8b5d-11f53794db4f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "ERAS-601: Potential best-in-class SHP2i, favorable profile for combination",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e55aa261-ca6a-4bad-947f-63dc8f0e803f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "e59a0f3e-ddef-44c1-ae92-8553bdc636c1",
      "evidence": "list/bullet points",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "38fcc8ef-5f62-4c55-9d35-8aee3c2e034e",
      "evidence": "Direct comparison of competitor clinical assets against internal asset benefits",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}